Market Overview:
Therapeutic vaccines are vaccines that are used as a therapeutic (treatment) rather than prophylactic (prevention) strategy. They help boost the body's natural defenses against various chronic diseases like cancer, autoimmune diseases, allergies, etc. Therapeutic vaccines stimulate the immune system to attack abnormal cells or slow their growth. They work by altering the way immune systems react to certain proteins produced by cancer or other chronic disease-causing agents. Market Dynamics: The therapeutic vaccines market is expected to witness significant growth over the forecast period owing to increasing research and development activities for novel vaccine development. For instance, in May 2020, Phio Pharmaceuticals Corp. announced the commencement of a Phase 1 clinical study to evaluate the efficacy and safety of its therapeutic DNA-based INTASYL compound, PH-762, for the treatment of non-melanoma skin cancers. Furthermore, growing prevalence of chronic diseases such as cancer and rising demand for alternative treatment options are also expected to boost the market growth during the forecast period. As per the National Cancer Institute, the global burden of cancer is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. However, high costs associated with therapeutic vaccine development and commercialization may hamper market growth over the forecast period. SWOT Analysis Strength: - Therapeutic Vaccines Market Demand helps boost the immune system and fights against diseases. - It has lower side effects and more targeted approach compared to other treatment options. - Continuous research and development activities are helping to launch novel and improved therapeutic vaccines. Weakness: - High development cost associated with therapeutic vaccines due to lengthy clinical trials. - Limited number of approved therapeutic vaccines. Opportunity: - Increasing prevalence of chronic diseases like cancer and infectious diseases worldwide. - Growing demand for personalized medicine and targeted treatment options. Threats: - Stringent regulatory approval process delays product launch. - High cost of maintenance associated with manufacturing of therapeutic vaccines. Key Takeaways The global therapeutic vaccines market is expected to witness high growth, exhibiting CAGR of 34% over the forecast period, due to increasing prevalence of chronic diseases and demand for targeted treatment options. The market size for therapeutic vaccines is US$ 2.68 Bn in 2023. The global therapeutic vaccines market is estimated to reach a value of over US$ 28 Bn by 2030. Regional analysis: North America is currently the dominant region in the therapeutic vaccines market and is estimated to continue its dominance over the forecast period. This is attributed to growing research activities in the region. Asia Pacific exhibits the fastest growth rate owing to increasing healthcare expenditures and expanding patient pool in the region. Key players analysis: Key players operating in the therapeutic vaccines market are Phio Pharmaceuticals Corp., GSK plc., Merck & Co., Inc., Pfizer Inc., Agenus Inc. Companies are focusing on research collaborations, acquisitions and new product launches to strengthen their market position. Read More: https://www.pressreleasebulletin.com/pharmaceutical-vaccines-driving-the-growth-of-therapeutic-vaccine-market/
0 Comments
Market Overview:
Trimethylolpropane triacrylate (TMPTA) is an organic compound that belongs to the acrylate family of monomers. It is majorly used as a reactive diluent in UV curable coatings and ink formulations owing to its excellent reactivity, flexibility, and adhesion properties. TMPTA finds widespread applications in industrial coatings, commercial printing inks, 3D printing resins and adhesives. Market Dynamics: The growth of the trimethylolpropane triacrylate market is primarily driven by rising demand from the coatings industry. Industrial coatings application accounts for over 30% of global TMPTA consumption. Growth in automotive, appliances, heavy machinery manufacturing is supporting demand for industrial coatings which in turn is fueling the need for trimethylolpropane triacrylate. Another major driver is growth of the commercial printing industry. TMPTA based UV curable inks offer benefits like high productivity and quality printing which is driving their adoption over conventional inks. This is positively impacting the trimethylolpropane triacrylate market. SWOT Analysis for Trimethylolpropane Triacrylate Market Demand Strength: - Trimethylolpropane triacrylate is widely used as polymerization vehicles which finds application in various industries like paints and coatings, adhesives and sealants offering growth opportunities. - The increasing R&D activities for developing new application areas boosts the market growth. - Growth of end use industries like paints and coatings further drive the demand. Weakness: - Price volatility of raw materials may hamper the market growth. - Stringent environmental regulations regarding VOC emissions can pose a threat. Opportunity: - Rising demand from construction industry for epoxy coatings and sealants offers significant growth opportunities. - Increasing use of trimethylolpropane triacrylate in UV curable formulations opens new avenues. Threats: - Availability of substitutes like pentaerythritol triacrylate poses threat to the market. - Fluctuations in crude oil prices affects the raw material costs. Key Takeaways The global Trimethylolpropane Triacrylate market is expected to witness high growth, exhibiting CAGR of 3.3% over the forecast period, due to increasing demand from paints and coatings industry. Rise in infrastructure development and construction activities drives the market growth. Regional analysis Asia Pacific dominates the global market and is estimated to grow at the fastest rate during the forecast period. This is attributed to swift industrialization and infrastructure growth in countries like China and India. North America also captures a significant share owing to the well-established end use industries in the region. Key players Key players operating in the Trimethylolpropane Triacrylate market are BASF S.E., J&K Scientific Ltd., Miwon Specialty Chemical Co., Ltd., and KPX Green Chemical Co. Ltd. BASF is one of the prominent players with wide product portfolio catering to various application segments. Read More: https://www.marketwebjournal.com/the-new-avanue-for-therapeutic-vaccines-market/ Market Overview:
Industrial hydrogen is widely used in various industries such as chemical, refining, general industry and metal fabrication. In chemical industry, it is used as feedstock for producing ammonia and methanol. In refining industry, hydrogen is used for processing heavier crudes to produce gasoline and diesel. Industrial hydrogen enhances product quality, increases production rate and minimizes emissions. It is produced through several production methods such as steam methane reforming of natural gas and coal gasification. Market Dynamics: Increasing focus on improving refining processes is a key factor driving growth of the industrial hydrogen market. Hydrogen aids in deep desulfurization and hydrocracking processes, which improve product quality of gasoline and diesel. It lowers sulfur content and increases diesel yields. Additionally, growing demand for industrial hydrogen from chemical industry is also expected to propel the market growth over the forecast period. Industrial hydrogen is used as a raw material in production of ammonia, which is further used to manufacture fertilizers. Rising global population is increasing the demand for food, which is augmenting the demand for fertilizers and thereby industrial hydrogen. Furthermore, shift toward production of cleaner fuel is another driver augmenting growth of the industrial hydrogen market. Hydrogen helps in processing heavier crudes to produce cleaner transportation fuels and lower transportation emissions. Segment Analysis The U.S. Europe And Asia Industrial Hydrogen Market can be segmented into by production & delivery mode and end-use industry. The production & delivery mode segment can be further divided into captive and merchant production & delivery mode. Presently, the captive production & delivery mode dominates the market as most hydrogen is produced by large oil refineries and chemical plants for internal use. This is because on-site production of hydrogen allows refineries and chemical plants to have continuous access to hydrogen throughout their operations. PEST Analysis Political: The governments in the US, Europe and Asia are focusing on developing policies to promote low carbon hydrogen production such as electrolysis powered by renewable energy sources. Several nations have announced targets and plans to scale up clean hydrogen production and use. Economic: The industrial hydrogen market is expected to witness growth due to rising demand from chemicals and refineries sector. The production cost of hydrogen is declining with technological advancements, favoring market expansion. Social: Growing awareness about environmental hazards of fossil fuels and carbon emissions is driving the demand for cleaner energy sources like hydrogen from end-use industries. Technological: Electrolytic hydrogen production using renewable energy is gaining traction to produce low carbon hydrogen. Carbon capture, utilization and storage technologies can also help increase clean hydrogen production. Key Takeaways The global U.S. Europe And Asia Industrial Hydrogen market is expected to witness high growth, exhibiting CAGR of 4.9% over the forecast period, due to increasing demand for hydrogen from chemical and petroleum refining industries. The market size for 2023 is estimated to be US$ 19.1 Bn. Regional analysis: Asia Pacific dominates the global industrial hydrogen market and is expected to continue its dominance during the forecast period. This is owing to large chemical and petroleum refining base in countries such as China, Japan, and India. China represents majority of the market share in the region. Key players analysis: Key players operating in the U.S. Europe And Asia Industrial Hydrogen market are Linde Group, Air Liquide, Air Products, Air Water, Taiyo Nippon Sanso, Messer Group, Yingde Gases. Players are focusing on expanding clean hydrogen production capacities by leveraging technologies such as electrolysis to cater to the growing demand. Read More: https://www.marketwebjournal.com/u-s-europe-and-asia-industrial-hydrogen-market-growth/ Market Overview:
Uterine fibroids are non-cancerous tumors that grow in or on the wall of the uterus. They are made up of muscle and fibrous tissue. Uterine fibroids are quite common and affect up to 80% of women by the age of 50. Symptoms include heavy or painful periods, pain in the pelvis or lower back, frequent urination, pain during sex, or a full feeling in the lower abdomen. Treatment options include medication, surgery, uterine fibroid embolization (UFE), high intensity focused ultrasound (HIFU) and magnetic resonance guided focused ultrasound (MRgFUS). Market Dynamics: The rising prevalence of uterine fibroids is a key driver fueling the growth of this market. According to the Uterine Fibroid Study conducted at the National Institutes of Health, around 70-80% of women develop uterine fibroids by the time they reach menopause. Furthermore, African American women are disproportionately affected, with up to 80% developing fibroids by age 50. The changing lifestyle and lack of physical activity have led to an increase in obesity rates which is another driver contributing to the higher risk of uterine fibroids. Additionally, growing awareness about treatment options and non-invasive procedures is encouraging more women to seek treatment. However, high costs associated with fibroid treatment procedures may hinder market growth over the forecast period. SWOT Analysis Strength: The U.S. Uterine Fibroid Treatment Market Demand has strong growth potential due to the rising prevalence of uterine fibroids in women. Non-invasive treatment options help reduce complications and recovery time. Moreover, the development of advanced minimally invasive procedures provides long-term treatment and relief from symptoms. Weakness: High cost of innovative treatment devices and procedures can restrict their adoption in the market. Lack of awareness about disease conditions and available treatment options among patients poses challenges. Opportunity: Growing research into novel treatment approaches will expand the product portfolio. Rising healthcare expenditure in the U.S. creates opportunities for market players. Threats: Stringent regulatory approvals for new treatment devices may delay their launch. Growing awareness about healthy lifestyles can lower prevalence of uterine fibroids over the long run. Key Takeaways The U.S. uterine fibroid treatment market is expected to witness high growth, exhibiting CAGR of 4.0% over the forecast period, due to increasing preference for minimally invasive procedures. These procedures such as MRI-guided focused ultrasound surgery and uterine artery embolization help preserve the uterus and avoid hysterectomy. Regional analysis: The North America region currently dominates the U.S. uterine fibroid treatment market due to growing geriatric population, rising incidence of uterine fibroids, and presence of advanced healthcare facilities. Factors such as rising awareness about disease conditions and availability of advanced diagnostics and treatment will boost the Asia Pacific market. Key players operating in the U.S. uterine fibroid treatment market are Blue Endo, Boston Scientific Corporation or its affiliates, CooperSurgical, Inc., Karl Storz SE & Co. KG, Myovant Sciences GmbH (Sumitovant Biopharma Ltd.), Halt Medical, Inc. (Hologic, Inc.), LiNA Medical ApS, Merit Medical Systems, Olympus Corporation, and Richard Wolf GmbH. These players are focusing on new product launches and strategic collaborations for market expansion. Read More: https://www.marketwebjournal.com/u-s-uterine-fibroid-treatment-market-growth-and-share/ Market Overview:
Urolithiasis, also known as kidney stones, are hard deposits made up of mineral and salt substances in the kidneys or urinary tract. Urolithiasis management devices are used for detecting, fragmenting and removing stones present in the kidneys or urinary tract. Some key urolithiasis management devices include intracorporeal lithotripters, ureteroscopes, nephroscopes, and ureteral stents. Intracorporeal lithotripters uses shock waves to break kidney stones into smaller fragments to pass out of the body naturally. Ureteroscopes and nephroscopes are used during ureteroscopy and percutaneous nephrolithotomy procedures respectively to locate and retrieve stones. Ureteral stents are placed after removal of stones to help heal and support the ureter. Market Dynamics: One of the major drivers for growth of urolithiasis management devices market is rising prevalence of kidney stones globally. According to the American Urological Association, approximately 10% to 15% of the world’s population will have a kidney stone in their lifetime. Moreover, changing dietary and lifestyle habits such as low water intake, obesity are contributing to high risk of developing kidney stones. Another driver is development of newer minimally invasive procedures and technologically advanced devices for effective management of kidney stones. For instance, miniaturized ureteroscopes, nanopulse lithotripsy, and robotic surgery are emerging as alternatives to conventional procedures. In addition, growing healthcare expenditure and awareness about availability of treatment options is further expected to fuel the market growth over the forecast period. Segment Analysis The global Urolithiasis Management Devices Market Demand is segmented into lithotripters, ureteral stents, and kidney stones removal devices. Amongst these, the lithotripters segment held the largest market share in 2022 owing to the increasing preference for non-invasive procedures such as extracorporeal shock wave lithotripsy (ESWL) for treating kidney stones. The procedure utilizes high-energy shock waves to breakdown kidney stones without surgical incisions. Furthermore, advancements leading to the development of improved lithotripters with minimal side effects have augmented the growth of this segment. PEST Analysis Political: Policies regarding reimbursement coverage for urolithiasis treatment procedures influencing the adoption of management devices. Economic: Rising healthcare expenditures on urolithiasis and favorable reimbursement scenarios driving the market growth. Social: Increasing awareness about availability of minimally invasive procedures for treating kidney stones boosting the market. Technological: Advancements in lithotripters and kidney stone removal devices facilitating non-invasive procedures with shorter recovery times fueling the market. Key Takeaways The global urolithiasis management devices market is expected to witness high growth, exhibiting CAGR of 4.8% over the forecast period, due to increasing geriatric population predisposed to kidney stone formation. Regionally, North America dominated the market and accounted for the largest revenue share in 2023 owing to expanding patient pool, favorable reimbursement policies, and presence of major players in the region. However, Asia Pacific is anticipated to witness fastest growth due to growing healthcare infrastructure and rising medical tourism in countries such as India and China. Key players operating in the urolithiasis management devices are Lumenis Ltd., Boston Scientific Corp, BD, Cook Medical, Karl Storz, Allengers Medical Systems, Inc, Olympus Corporation, Electro Medical Systems SA, Dornier MedTech GmbH, Direx Group., HealthTronics, Inc., CONMED Corporation., Applaud Medical, Inc., Potent Medical., and other prominent players. The global leaders are focusing on new product launches and strategic collaborations to strengthen their market position. Read More: https://www.marketwebjournal.com/urolithiasis-management-devices-market-to-witness-high-growth/ |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
March 2024
Categories
All
|